STOCK TITAN

Nexera Technologies Warrant (NEXRW) Financials

NEXRW NASDAQ
FY2025 annual
Revenue $16.8M +23.0% YoY
Net Income -$3.7M n/m YoY
EPS (Diluted) -$81.07 YoY not available
Free Cash Flow -$6.2M n/m YoY
Source SEC Filings Latest period FY2025, ended Dec 31, 2025 Reported Currency USD FYE December

Newest figures come from the filing for FY2025, filed Apr 1, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the NEXRW SEC filings page.

Nexera Technologies Ltd Warrant (NEXRW) reported $16.8M in revenue for fiscal year 2025, up 23.0% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings.

Rhea AI NEXRW FY2025

Revenue growth is expanding, but operating costs are outrunning gross profit, leaving growth dependent on external financing rather than internal cash.

In FY2025, the net loss narrowed to $3.7M even as the operating loss widened to $7.8M; the improvement therefore came below operating income, not from core operations. The tax line flipped from expense to benefit, while operating cash flow of -$6.2M nearly matched free cash flow of -$6.2M, showing the cash drain was operational rather than mainly reinvestment.

Revenue growth rose 23.0%, yet gross profit rose only 13.2%, so additional sales are producing less incremental gross profit. SG&A reached $9.2M from $6.7M, adding pressure that gross profit did not absorb; operating margin slipped from -45.3% to -46.6%.

Leverage is modest in the reported capital structure: long-term debt was $350K against $11.5M of equity. Yet external financing supplied $9.8M while operating cash flow was -$6.2M, indicating that growth and its working-capital demands were funded outside operations.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&DIntensity Revenue Progress BurnTrend BalanceSheet 44 / 100
Financial Health Score (5 of 6 dimensions) 44/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed: here 5 of 6, with the others left out rather than counted as zero. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Nexera Technologies Ltd Warrant's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
14

Nexera Technologies Ltd Warrant held $1.6M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations used $6.2M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Nexera Technologies Ltd Warrant scores 14/100 among other emerging companies.

Dilution
95

Nexera Technologies Ltd Warrant had 250,727 shares outstanding at the end of fiscal year 2025. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and Nexera Technologies Ltd Warrant scores 95/100 among other emerging companies.

R&D Intensity
n/a

Not available for Nexera Technologies Ltd Warrant, so it is left out of the overall score, which averages the 5 of 6 dimensions that can be computed.

Revenue Progress
70

Nexera Technologies Ltd Warrant reported revenue of $16.8M in fiscal year 2025, against $13.7M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and Nexera Technologies Ltd Warrant scores 70/100 among other emerging companies.

Burn Trend
18

Nexera Technologies Ltd Warrant's operations used $6.2M of cash in fiscal year 2025, against $5.9M used in fiscal year 2024. Burn Trend ranks emerging companies on which way that figure has moved over three years, and Nexera Technologies Ltd Warrant scores 18/100 among other emerging companies.

Balance Sheet
24

Nexera Technologies Ltd Warrant's cash, cash equivalents and investments came to $1.6M at the end of fiscal year 2025, against $9.8M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Nexera Technologies Ltd Warrant scores 24/100 among other emerging companies.

Piotroski F-Score Partial
2/8

Nexera Technologies Ltd Warrant passes 2 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality No Cash Backing
N/A

Nexera Technologies Ltd Warrant reported a net loss of $3.7M while operations used $6.2M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

Nexera Technologies Ltd Warrant reported an operating loss of $7.8M against $135 in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$16.8M
YoY+23.0%
5Y CAGR+49.0%

Nexera Technologies Ltd Warrant generated $16.8M in revenue in fiscal year 2025. This represents an increase of 23.0% from the prior year.

Net Income
-$3.7M
YoYn/m

Nexera Technologies Ltd Warrant reported a net loss of $3.7M in fiscal year 2025. The change from the prior year is not meaningful, because that figure was zero or negative.

EPS (Diluted)
-$81.07

Nexera Technologies Ltd Warrant earned -$81.07 per diluted share (EPS) in fiscal year 2025.

EBITDA

Not reported for fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow
-$6.2M
YoYn/m

Nexera Technologies Ltd Warrant recorded an outflow of $6.2M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. The change from the prior year is not meaningful, because that figure was zero or negative.

Cash & Debt
$1.6M
YoY-36.2%
5Y CAGR+41.2%

Nexera Technologies Ltd Warrant held $1.6M in cash against $350K in long-term debt as of fiscal year 2025, with $4.2M of liabilities due within a year.

Shares Outstanding
250,727

Nexera Technologies Ltd Warrant had 250,727 shares outstanding in fiscal year 2025.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin
10.5%
YoY-0.9pp
5Y change-38.6pp

Nexera Technologies Ltd Warrant's gross margin was 10.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 0.9 percentage points from the prior year.

Operating Margin
-46.6%
YoY-1.3pp
5Y change-64.9pp

Nexera Technologies Ltd Warrant's operating margin was -46.6% in fiscal year 2025, reflecting core business profitability. This is down 1.3 percentage points from the prior year.

Net Margin
-21.9%
YoY+35.2pp
5Y change-26.7pp

Nexera Technologies Ltd Warrant's net profit margin was -21.9% in fiscal year 2025, showing the share of revenue converted to profit. This is up 35.2 percentage points from the prior year.

Return on Equity
-32.1%
YoY+108.3pp
5Y change-64.1pp

Nexera Technologies Ltd Warrant's ROE was -32.1% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 108.3 percentage points from the prior year.

Capital Allocation

Capital Expenditures
$11K
YoY-92.4%
5Y CAGR+61.5%

Nexera Technologies Ltd Warrant invested $11K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 92.4% from the prior year.

R&D Spending

Not reported for fiscal year 2025.

Share Buybacks

Not reported for fiscal year 2025.

NEXRW Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NEXRW annual income statement
MetricFY25FilingFY24FilingFY23FilingFY22FilingFY21FilingFY20Filing
Revenue$16.8M+23.0%$13.7M+36.8%$10.0M+70.8%$5.9M-10.0%$6.5M+184.4%$2.3M
Cost of Revenue$15.1M+24.2%$12.1M+34.2%$9.0M+78.5%$5.1M+11.0%$4.6M+291.4%$1.2M
Gross Profit$1.8M+13.2%$1.6M+60.8%$976K+22.2%$799K-59.0%$1.9M+73.4%$1.1M
SG&A Expenses$9.2M+36.7%$6.7M+31.6%$5.1M-4.1%$5.3M+90.1%$2.8M+296.9%$704K
Operating Income-$7.8Mn/m-$6.2Mn/m-$5.1Mn/m-$4.5Mn/m-$932K-321.9%$420K
EBITDAN/A-$5.4Mn/m-$4.4Mn/m-$3.9Mn/m-$408KN/A
Interest Expense$135N/AN/A$203K-46.7%$381KN/A
Income Tax-$736K-337.4%$310K+868.8%$32Kn/m-$6Kn/m-$21K-127.6%$76K
Net Income-$3.7Mn/m-$7.8Mn/m-$4.6Mn/m-$2.2Mn/m-$1.5M-1475.0%$112K
EPS (Basic)-$81.07-$2835.12-$12010.49-$43.16-$3.73$0.04
EPS (Diluted)-$81.07-$2835.12-$12010.49-$43.16-$3.73$0.04
Diluted Shares (Avg)45,3572,75338351,032413,1923M

Not reported in any period shown, so not listed: R&D Expenses.

NEXRW Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NEXRW annual balance sheet
MetricFY25FilingFY24FilingFY23FilingFY22FilingFY21FilingFY20Filing
Total Assets$22.2M+61.8%$13.7M+12.1%$12.2M-22.4%$15.8M+112.8%$7.4MN/A
Current Assets$7.6M+0.6%$7.5M+81.2%$4.2M-62.3%$11.0M+445.7%$2.0MN/A
Cash & Equivalents$1.6M-36.2%$2.6M+379.3%$535K-93.4%$8.1M+1970.5%$393K+35.1%$291K
Short-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0
Inventory$4.7M+15.2%$4.1M+69.8%$2.4M+33.2%$1.8M+46.0%$1.2MN/A
Accounts Receivable$691K+64.5%$420K-33.2%$629K+92.4%$327K-10.7%$366KN/A
Long-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0
Goodwill$951KN/AN/AN/AN/AN/A
Total Liabilities$9.8M+19.4%$8.2M+119.1%$3.7M+26.2%$3.0M-52.0%$6.2MN/A
Current Liabilities$4.2M+143.3%$1.7M-25.7%$2.3M+260.6%$640K-69.1%$2.1MN/A
Non-Current Liabilities$5.6M-13.5%$6.5M+354.4%$1.4M-38.6%$2.3M-43.4%$4.1MN/A
Long-Term Debt$350KN/AN/AN/AN/A$250K
Total Equity$11.5M+106.1%$5.6M-34.7%$8.5M-33.6%$12.8M+923.2%$1.3M+258.0%$350K
Retained Earnings-$19.8Mn/m-$16.1Mn/m-$8.3Mn/m-$3.7Mn/m-$1.5MN/A

NEXRW Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NEXRW annual cash flow statement
MetricFY25FilingFY24FilingFY23FilingFY22FilingFY21FilingFY20Filing
Operating Cash Flow-$6.2Mn/m-$5.9Mn/m-$2.7Mn/m-$4.8Mn/m-$863K-784.9%$126K
Depreciation & AmortizationN/A$788K+6.8%$738K+29.5%$570K+8.8%$524KN/A
Stock-Based Compensation$688KN/AN/AN/A$60KN/A
Capital Expenditures$11K-92.4%$144K+476.0%$25K-39.0%$41K+1950.0%$2K+100.0%$1K
Free Cash Flow-$6.2Mn/m-$6.0Mn/m-$2.7Mn/m-$4.9Mn/m-$865K-792.0%$125K
Investing Cash Flow-$4.5Mn/m-$572Kn/m-$4.8Mn/m-$41Kn/m-$4.7Mn/m-$101K
Financing Cash Flow$9.8M+15.1%$8.5Mn/m-$86K-100.7%$12.6M+121.7%$5.7M+3481.8%$159K

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

NEXRW Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NEXRW annual financial ratios
MetricFY25FilingFY24FilingFY23FilingFY22FilingFY21FilingFY20Filing
Gross Margin10.5%-0.9pp11.5%+1.7pp9.8%-3.9pp13.6%-16.3pp29.9%-19.2pp49.1%
Operating Margin-46.6%-1.3pp-45.3%+5.5pp-50.8%+26.2pp-77.0%-62.7pp-14.3%-32.7pp18.4%
Net Margin-21.9%+35.2pp-57.0%-11.1pp-45.9%-8.4pp-37.6%-13.9pp-23.7%-28.5pp4.9%
Return on Equity-32.1%+108.3pp-140.4%-86.4pp-54.0%-36.9pp-17.2%+105.7pp-122.9%-154.9pp32.0%
Return on Assets-16.6%+40.3pp-56.9%-19.3pp-37.6%-23.6pp-14.0%+6.8pp-20.8%N/A
Current Ratio1.82-2.6x4.40+2.6x1.80-15.4x17.24+16.3x0.97N/A
Debt-to-Equity0.03N/AN/AN/AN/A0.71
Liabilities-to-Equity0.85-0.6x1.47+1.0x0.44+0.2x0.23-4.7x4.92N/A
Asset Turnover0.76-0.2x1.00+0.2x0.82+0.4x0.37-0.5x0.88N/A
FCF Margin-37.0%+6.9pp-44.0%-17.1pp-26.9%+56.4pp-83.3%-70.0pp-13.3%-18.8pp5.5%

Frequently Asked Questions

Nexera Technologies Ltd Warrant (NEXRW) reported $16.8M in total revenue for fiscal year 2025. This represents a 23.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Nexera Technologies Ltd Warrant (NEXRW) revenue grew by 23.0% year-over-year, from $13.7M to $16.8M in fiscal year 2025.

No, Nexera Technologies Ltd Warrant (NEXRW) reported a net loss of $3.7M in fiscal year 2025, with a net profit margin of -21.9%.

Nexera Technologies Ltd Warrant (NEXRW) reported diluted earnings per share of -$81.07 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

As of fiscal year 2025, Nexera Technologies Ltd Warrant (NEXRW) had $1.6M in cash and equivalents against $350K in long-term debt.

Nexera Technologies Ltd Warrant (NEXRW) had a gross margin of 10.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Nexera Technologies Ltd Warrant (NEXRW) had an operating margin of -46.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Nexera Technologies Ltd Warrant (NEXRW) had a net profit margin of -21.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Nexera Technologies Ltd Warrant (NEXRW) has a return on equity of -32.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Nexera Technologies Ltd Warrant (NEXRW) recorded an outflow of $6.2M in free cash flow during fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Nexera Technologies Ltd Warrant (NEXRW) recorded an outflow of $6.2M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Nexera Technologies Ltd Warrant (NEXRW) had $22.2M in total assets as of fiscal year 2025, including both current and long-term assets.

Nexera Technologies Ltd Warrant (NEXRW) invested $11K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Nexera Technologies Ltd Warrant (NEXRW) had 250,727 shares outstanding as of fiscal year 2025.

Nexera Technologies Ltd Warrant (NEXRW) had a current ratio of 1.82 as of fiscal year 2025, which is generally considered healthy.

Nexera Technologies Ltd Warrant (NEXRW) had a debt-to-equity ratio of 0.03 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.

Nexera Technologies Ltd Warrant (NEXRW) had a liabilities-to-equity ratio of 0.85 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.

Nexera Technologies Ltd Warrant (NEXRW) had a return on assets of -16.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Nexera Technologies Ltd Warrant (NEXRW) has a Piotroski F-Score of 2 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Nexera Technologies Ltd Warrant (NEXRW) reported a net loss of $3.7M while operations used $6.2M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Nexera Technologies Ltd Warrant (NEXRW) reported an operating loss of $7.8M against $135 in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Nexera Technologies Ltd Warrant (NEXRW) scores 44 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is the average of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. For Nexera Technologies Ltd Warrant it averages the 5 of 6 dimensions that can be computed; the others are left out rather than counted as zero. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top